DK3166960T3 - Lav-substituerede polymyxiner og sammensætninger deraf - Google Patents
Lav-substituerede polymyxiner og sammensætninger deraf Download PDFInfo
- Publication number
- DK3166960T3 DK3166960T3 DK15735887.0T DK15735887T DK3166960T3 DK 3166960 T3 DK3166960 T3 DK 3166960T3 DK 15735887 T DK15735887 T DK 15735887T DK 3166960 T3 DK3166960 T3 DK 3166960T3
- Authority
- DK
- Denmark
- Prior art keywords
- polymyxines
- substituted
- compositions
- low
- substituted polymyxines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- C07K7/62—Polymyxins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462022399P | 2014-07-09 | 2014-07-09 | |
| PCT/EP2015/064764 WO2016005223A1 (en) | 2014-07-09 | 2015-06-29 | Low substituted polymyxins and compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3166960T3 true DK3166960T3 (da) | 2019-10-14 |
Family
ID=53539668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15735887.0T DK3166960T3 (da) | 2014-07-09 | 2015-06-29 | Lav-substituerede polymyxiner og sammensætninger deraf |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10711040B2 (da) |
| EP (1) | EP3166960B1 (da) |
| JP (1) | JP2017523953A (da) |
| KR (1) | KR20170032348A (da) |
| CN (1) | CN106661090A (da) |
| AU (1) | AU2015286956A1 (da) |
| BR (1) | BR112017000228A2 (da) |
| CA (1) | CA2949328C (da) |
| DK (1) | DK3166960T3 (da) |
| EA (1) | EA201692569A1 (da) |
| ES (1) | ES2749053T3 (da) |
| HU (1) | HUE046814T2 (da) |
| IL (1) | IL249695A0 (da) |
| PT (1) | PT3166960T (da) |
| SI (1) | SI3166960T1 (da) |
| WO (1) | WO2016005223A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA027067B1 (ru) | 2013-01-11 | 2017-06-30 | Кселлия Фармасьютикалз Апс | Полимиксины, композиции, способы получения и способы применения |
| RS60874B1 (sr) | 2014-10-03 | 2020-11-30 | Xellia Pharmaceuticals Aps | Kompozicije |
| KR102494511B1 (ko) | 2014-10-03 | 2023-01-31 | 셀리아 파마슈티칼즈 에이피에스 | 흡입 장치 |
| CN110845579B (zh) * | 2019-08-08 | 2022-04-19 | 上海市食品药品检验研究院 | 一种多黏菌素e组分及其光化学产物和液相色谱-质谱分析方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1062895A (en) | 1962-12-13 | 1967-03-22 | Wellcome Found | Sulphomethyl derivatives of polymxin |
| FR1586834A (da) | 1968-02-12 | 1970-03-06 | ||
| DE1906699A1 (de) | 1968-02-12 | 1970-02-05 | Pfizer | Neue Polymyxinderivate und Verfahren zu deren Herstellung |
| AU611030B2 (en) | 1988-04-07 | 1991-05-30 | Edward Shanbrom | Non-thrombogenic intravascular time release catheter |
| WO1998020836A2 (en) | 1996-11-15 | 1998-05-22 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| US5767068A (en) * | 1997-02-13 | 1998-06-16 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| CA2447600C (en) | 2001-05-18 | 2015-10-20 | Chiron Corporation | Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| US20040022740A1 (en) | 2001-07-10 | 2004-02-05 | Baker William R. | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| DE60217060T2 (de) | 2002-03-01 | 2007-06-21 | Chiesi Farmaceutici S.P.A. | Pharmazeutische Zusammensetzungen, die Lungensurfactants und ein Polymyxin umfassen und verbesserte Oberflächenspannung-senkende Eigenschaften haben |
| WO2008025560A1 (en) | 2006-09-01 | 2008-03-06 | Pari Pharma Gmbh | Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy |
| US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
| PL2470555T3 (pl) | 2009-10-30 | 2015-05-29 | Xellia Pharmaceuticals Aps | Sposób oczyszczania kolistyny i oczyszczone składniki kolistyny |
| WO2012168820A1 (en) | 2011-06-08 | 2012-12-13 | Pfizer Inc. | Polymyxin derivatives useful as antibacterial agents |
| EA027067B1 (ru) * | 2013-01-11 | 2017-06-30 | Кселлия Фармасьютикалз Апс | Полимиксины, композиции, способы получения и способы применения |
| TW201522364A (zh) | 2013-06-07 | 2015-06-16 | Xellia Pharmaceuticals Aps | 黏菌素甲磺酸鈉（ｃｍｓ）之定性方法 |
| RS60874B1 (sr) | 2014-10-03 | 2020-11-30 | Xellia Pharmaceuticals Aps | Kompozicije |
-
2015
- 2015-06-29 CN CN201580037142.8A patent/CN106661090A/zh active Pending
- 2015-06-29 WO PCT/EP2015/064764 patent/WO2016005223A1/en active Application Filing
- 2015-06-29 EP EP15735887.0A patent/EP3166960B1/en active Active
- 2015-06-29 SI SI201530929T patent/SI3166960T1/sl unknown
- 2015-06-29 EA EA201692569A patent/EA201692569A1/ru unknown
- 2015-06-29 KR KR1020177003440A patent/KR20170032348A/ko unknown
- 2015-06-29 AU AU2015286956A patent/AU2015286956A1/en not_active Abandoned
- 2015-06-29 ES ES15735887T patent/ES2749053T3/es active Active
- 2015-06-29 HU HUE15735887A patent/HUE046814T2/hu unknown
- 2015-06-29 US US15/324,882 patent/US10711040B2/en active Active
- 2015-06-29 PT PT157358870T patent/PT3166960T/pt unknown
- 2015-06-29 BR BR112017000228A patent/BR112017000228A2/pt not_active Application Discontinuation
- 2015-06-29 JP JP2016570088A patent/JP2017523953A/ja active Pending
- 2015-06-29 CA CA2949328A patent/CA2949328C/en active Active
- 2015-06-29 DK DK15735887.0T patent/DK3166960T3/da active
-
2016
- 2016-12-21 IL IL249695A patent/IL249695A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170032348A (ko) | 2017-03-22 |
| IL249695A0 (en) | 2017-02-28 |
| AU2015286956A1 (en) | 2016-12-08 |
| CA2949328C (en) | 2023-01-31 |
| PT3166960T (pt) | 2019-10-25 |
| SI3166960T1 (sl) | 2019-12-31 |
| CN106661090A (zh) | 2017-05-10 |
| JP2017523953A (ja) | 2017-08-24 |
| US20170218024A1 (en) | 2017-08-03 |
| BR112017000228A2 (pt) | 2017-10-31 |
| EP3166960B1 (en) | 2019-08-07 |
| CA2949328A1 (en) | 2016-01-14 |
| US10711040B2 (en) | 2020-07-14 |
| EA201692569A1 (ru) | 2017-05-31 |
| EP3166960A1 (en) | 2017-05-17 |
| ES2749053T3 (es) | 2020-03-18 |
| WO2016005223A1 (en) | 2016-01-14 |
| HUE046814T2 (hu) | 2020-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20230014I1 (fi) | Foslevodopa ja foskarbidopa | |
| DK3495023T3 (da) | Semifluorerede forbindelser og sammensætninger deraf | |
| DK3210977T3 (da) | Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf | |
| DK3234133T3 (da) | Crispr-baserede sammensætninger og fremgangsmåder til anvendelse | |
| DK3212255T3 (da) | Selvorienterende sprøjte og sprøjtegrænseflade | |
| DK3215147T3 (da) | Neurodæmpende norketamin-forbindelser og fremgangsmåder | |
| DK3169741T3 (da) | Forbedrede bindemiddelsammensætninger og anvendelser deraf | |
| DK3218358T3 (da) | Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner | |
| KR20180084891A (ko) | 구조 조성물 및 방법 | |
| DK3018183T3 (da) | Halogenolefinbaseret sammensætning og anvendelse deraf | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3316909T3 (da) | Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder | |
| DK3089741T3 (da) | Farmaceutiske sammensætninger omfattende azd9291 | |
| DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
| DK3220750T3 (da) | Oral rehydreringssammensætning og fremgangsmåder dertil | |
| DK3265641T3 (da) | Stigørenhed og fremgangsmåde | |
| DK3194564T3 (da) | Trichodermasammensætninger og anvendelsesfremgangsmåder | |
| DK3212776T3 (da) | Sammensætninger og fremgangsmåder i forbindelse med beta-glucosidase | |
| DK3161139T3 (da) | Tlr-4-specifikke aptamerer og anvendelser heraf | |
| DK3236991T3 (da) | Fgf21-derivater og anvendelser deraf | |
| DK3209773T3 (da) | Prolintolerante tripeptidylpeptidaser og anvendelser deraf | |
| DK3223796T3 (da) | Farmaceutiske sammensætninger, fremstilling og anvendelser deraf | |
| DK3324932T3 (da) | Sammensætninger og fremgangsmåder for nanopartikel lyofile former | |
| DK3231793T3 (da) | Dihydropyromidin-2-on-forbindelser og medicinske anvendelser deraf | |
| DK3128005T3 (da) | Sirp-alfa-variantkonstruktioner og anvendelser deraf |